JPWO2022147443A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022147443A5 JPWO2022147443A5 JP2023539282A JP2023539282A JPWO2022147443A5 JP WO2022147443 A5 JPWO2022147443 A5 JP WO2022147443A5 JP 2023539282 A JP2023539282 A JP 2023539282A JP 2023539282 A JP2023539282 A JP 2023539282A JP WO2022147443 A5 JPWO2022147443 A5 JP WO2022147443A5
- Authority
- JP
- Japan
- Prior art keywords
- aac
- composition
- administered
- antibody
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063131506P | 2020-12-29 | 2020-12-29 | |
| US63/131,506 | 2020-12-29 | ||
| PCT/US2021/073143 WO2022147443A1 (en) | 2020-12-29 | 2021-12-28 | Methods for treating cancers with activating antigen carriers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024501023A JP2024501023A (ja) | 2024-01-10 |
| JP2024501023A5 JP2024501023A5 (https=) | 2024-12-25 |
| JPWO2022147443A5 true JPWO2022147443A5 (https=) | 2024-12-25 |
Family
ID=80123138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023539282A Pending JP2024501023A (ja) | 2020-12-29 | 2021-12-28 | 活性化抗原担体を用いるがんを処置するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20220296691A1 (https=) |
| EP (1) | EP4271408A1 (https=) |
| JP (1) | JP2024501023A (https=) |
| CN (1) | CN117042796A (https=) |
| CA (1) | CA3203356A1 (https=) |
| WO (1) | WO2022147443A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202241466A (zh) * | 2020-12-29 | 2022-11-01 | 美商Ｓｑｚ生物科技公司 | 以經修飾ｐｂｍｃ治療癌症之方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107058101B (zh) | 2011-10-17 | 2021-06-01 | 麻省理工学院 | 细胞内传递 |
| EP3033184B1 (en) | 2013-08-16 | 2021-03-31 | Massachusetts Institute of Technology | Selective delivery of material to cells |
| JP7523203B2 (ja) | 2014-10-31 | 2024-07-26 | マサチューセッツ インスティテュート オブ テクノロジー | 生体分子の免疫細胞への送達 |
| SG10201912910PA (en) | 2015-07-09 | 2020-02-27 | Massachusetts Inst Technology | Delivery of materials to anucleate cells |
| ES2930017T3 (es) | 2015-09-04 | 2022-12-05 | Sqz Biotechnologies Co | Suministro intracelular de biomoléculas mediado por una superficie con poros |
| JP7602702B2 (ja) | 2016-05-03 | 2024-12-19 | ステムセル テクノロジーズ カナダ インコーポレーテッド | 寛容性を誘導するための生体分子の細胞内送達 |
| KR102490952B1 (ko) | 2016-05-03 | 2023-01-19 | 에스큐지 바이오테크놀로지스 컴퍼니 | 관용을 유도하는 생체분자의 세포내 전달 |
| US12599656B2 (en) | 2018-03-12 | 2026-04-14 | Stemcell Technologies Canada Inc. | Methods for treating HPV-associated diseases |
| EP3765068A2 (en) | 2018-03-12 | 2021-01-20 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to modify immune response |
| KR20210070338A (ko) | 2018-10-04 | 2021-06-14 | 에스큐지 바이오테크놀로지스 컴퍼니 | 항원 제시 세포 기능을 증진시키기 위한 생체분자의 세포내 전달 |
| WO2020154696A1 (en) | 2019-01-25 | 2020-07-30 | Sqz Biotechnologies Company | Anucleate cell-derived vaccines |
| CA3131701A1 (en) | 2019-02-28 | 2020-09-03 | Sqz Biotechnologies Company | Delivery of biomolecules to pbmcs to modify an immune response |
-
2021
- 2021-12-28 US US17/563,787 patent/US20220296691A1/en not_active Abandoned
- 2021-12-28 JP JP2023539282A patent/JP2024501023A/ja active Pending
- 2021-12-28 CA CA3203356A patent/CA3203356A1/en active Pending
- 2021-12-28 EP EP21851940.3A patent/EP4271408A1/en active Pending
- 2021-12-28 WO PCT/US2021/073143 patent/WO2022147443A1/en not_active Ceased
- 2021-12-28 CN CN202180094380.8A patent/CN117042796A/zh active Pending
-
2025
- 2025-04-22 US US19/185,850 patent/US20250326802A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021517895A5 (https=) | ||
| JP7244461B2 (ja) | 養子細胞療法のための改良型細胞培養方法 | |
| US20230383250A1 (en) | Methods of cell culture for adoptive cell therapy | |
| Brooks et al. | Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection | |
| Mackinnon et al. | Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells | |
| Fogh et al. | Continuous cultivation of epithelial cell strain (FL) from human amniotic membrane. | |
| Copeland et al. | Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax | |
| Zuliani et al. | Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy | |
| JP5070045B2 (ja) | 新規人工抗原提示細胞およびそれらの用途 | |
| Bachmann et al. | Maintenance of memory CTL responses by T helper cells and CD40‐CD40 ligand: antibodies provide the key | |
| JPWO2019178005A5 (https=) | ||
| JP2021517813A5 (https=) | ||
| JP2021138721A (ja) | Ｈｉｖ予備免疫化および免疫療法 | |
| JP2001504323A (ja) | 抗原特異的ｔ細胞の精製 | |
| CN111566201A (zh) | 使用用于表达嵌合抗原受体(car)或转基因t细胞受体(tcr)的病毒载体转导细胞的方法 | |
| JP2018534928A (ja) | 形質導入のための方法、キット、作用物質および装置 | |
| JP2004267220A (ja) | Ｔ細胞の増殖を選択的に刺激する方法 | |
| US20210301255A1 (en) | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto | |
| JP2021536260A5 (https=) | ||
| JP2020534313A (ja) | 養子療法のための抗原特異的ｔ細胞を含む細胞組成物 | |
| CN116261466A (zh) | 通用抗原特异性t细胞库及其制备和治疗性使用方法 | |
| JPWO2019178006A5 (https=) | ||
| Wang et al. | Large-scale manufacturing and characterization of CMV-CD19CAR T cells | |
| Halwani et al. | Generation and maintenance of human memory cells during viral infection | |
| JP7043114B2 (ja) | 細胞を活性化させるための方法およびキット |